HK1067278A1 - Stabilized azithromycin compositions - Google Patents
Stabilized azithromycin compositionsInfo
- Publication number
- HK1067278A1 HK1067278A1 HK05100860.2A HK05100860A HK1067278A1 HK 1067278 A1 HK1067278 A1 HK 1067278A1 HK 05100860 A HK05100860 A HK 05100860A HK 1067278 A1 HK1067278 A1 HK 1067278A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- azithromycin
- compositions
- stabilized
- stabilized azithromycin
- antioxidant
- Prior art date
Links
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 title abstract 7
- 229960004099 azithromycin Drugs 0.000 title abstract 7
- 239000000203 mixture Substances 0.000 title abstract 6
- 239000003963 antioxidant agent Substances 0.000 abstract 2
- 230000003078 antioxidant effect Effects 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 230000000087 stabilizing effect Effects 0.000 abstract 2
- 230000015556 catabolic process Effects 0.000 abstract 1
- 238000000975 co-precipitation Methods 0.000 abstract 1
- 238000006731 degradation reaction Methods 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 238000003801 milling Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33634601P | 2001-10-18 | 2001-10-18 | |
US33193101P | 2001-11-21 | 2001-11-21 | |
US34129501P | 2001-12-17 | 2001-12-17 | |
PCT/US2002/033339 WO2003032922A2 (en) | 2001-10-18 | 2002-10-18 | Stabilized azithromycin compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1067278A1 true HK1067278A1 (en) | 2005-04-08 |
Family
ID=27406829
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK05100860.2A HK1067278A1 (en) | 2001-10-18 | 2005-02-02 | Stabilized azithromycin compositions |
Country Status (13)
Country | Link |
---|---|
US (3) | US6764997B2 (xx) |
EP (1) | EP1446010B1 (xx) |
AT (1) | ATE428403T1 (xx) |
AU (1) | AU2002335087A1 (xx) |
CA (1) | CA2463619C (xx) |
DE (1) | DE60232005D1 (xx) |
DK (1) | DK1446010T3 (xx) |
ES (1) | ES2324527T3 (xx) |
HK (1) | HK1067278A1 (xx) |
HU (1) | HUP0402291A2 (xx) |
IL (1) | IL161398A0 (xx) |
PT (1) | PT1446010E (xx) |
WO (1) | WO2003032922A2 (xx) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6861413B2 (en) | 2001-05-22 | 2005-03-01 | Pfizer Inc. | Stable non-dihydrate azithromycin oral suspensions |
EA007618B1 (ru) | 2001-05-22 | 2006-12-29 | Пфайзер Продактс Инк. | Кристаллический полуторогидрат азитромицина, содержащая его фармацевтическая композиция и способ лечения на его основе |
US20080149521A9 (en) * | 2001-10-18 | 2008-06-26 | Michael Pesachovich | Methods of stabilizing azithromycin |
NZ532707A (en) * | 2001-12-21 | 2006-07-28 | Pfizer Prod Inc | Directly compressible formulations of azithromycin |
BR0215175A (pt) * | 2001-12-21 | 2004-12-28 | Pfizer Prod Inc | Métodos para a granulação úmida de azitromicina |
JP2005526020A (ja) * | 2002-02-01 | 2005-09-02 | ファイザー・プロダクツ・インク | アジスロマイシンの乾式造粒配合物 |
EP1594762A1 (en) * | 2003-02-19 | 2005-11-16 | Teva Pharmaceutical Industries Limited | Methods of stabilizing azithromycin during storage by packaging in a gas impermeable container |
EP1606299A1 (en) * | 2003-03-25 | 2005-12-21 | Teva Pharmaceutical Industries Ltd. | Degradation products of azithromycin, and methods for their identification |
US7410952B2 (en) * | 2003-04-17 | 2008-08-12 | Sandoz Ag | Derivatives of azithromycin |
US20070185194A1 (en) * | 2003-07-01 | 2007-08-09 | Kamal Mehta | Stable oral compositions of azithromycin monohydrate |
US20050013835A1 (en) * | 2003-07-15 | 2005-01-20 | Pfizer Inc. | Stable non-dihydrate azithromycin oral suspensions |
CA2540104A1 (en) * | 2003-09-30 | 2005-04-07 | Solubest Ltd. | Water soluble nanoparticles comprising inclusion complexes |
US20060116336A1 (en) * | 2004-03-17 | 2006-06-01 | American Pharmaceutical Partners, Inc. | Lyophilized azithromycin formulation |
US7468428B2 (en) * | 2004-03-17 | 2008-12-23 | App Pharmaceuticals, Llc | Lyophilized azithromycin formulation |
CA2591744A1 (en) * | 2004-12-21 | 2006-06-29 | Pfizer Products Inc. | Stable non-dihydrate azithromycin oral suspensions |
US20060198895A1 (en) * | 2005-03-07 | 2006-09-07 | Kotliar Eleonora M | Azithromycin powder for oral suspension compositions |
US8906823B2 (en) * | 2007-09-24 | 2014-12-09 | Basf Corporation | Pollutant emission control sorbents and methods of manufacture and use |
TWI592159B (zh) | 2007-11-16 | 2017-07-21 | 威佛(國際)股份有限公司 | 藥學組成物 |
US8106111B2 (en) | 2009-05-15 | 2012-01-31 | Eastman Chemical Company | Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions |
WO2011015219A1 (en) | 2009-08-06 | 2011-02-10 | Shifa Pharmed Industrial Group Co. | Process for the purification of azithromycin by separation from its thermal degradation products and/or isomers |
RU2512683C2 (ru) * | 2012-06-08 | 2014-04-10 | Общество с ограниченной ответственностью "ВИК-здоровье животных" | Антибактериальная инъекционная фармацевтическая композиция |
CN117503775A (zh) * | 2017-04-28 | 2024-02-06 | 自由生物有限公司 | 治疗特应性皮炎以及提高活性药物成分稳定性的制剂、方法、试剂盒和剂型 |
RU2666607C1 (ru) * | 2017-05-03 | 2018-09-11 | Общество С Ограниченной Ответственностью "Вик - Здоровье Животных" | Способ повышения стабильности инъекционной фармацевтической композиции |
US11654124B2 (en) | 2019-07-29 | 2023-05-23 | Amneal Pharmaceuticals Llc | Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives |
US10792262B1 (en) | 2019-07-29 | 2020-10-06 | Saol International Limited | Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives |
CN111450065B (zh) * | 2020-04-22 | 2022-04-01 | 南京嘉晨医药科技有限公司 | 一种阿奇霉素干混悬剂的制备方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI8110592A8 (en) * | 1981-03-06 | 1996-06-30 | Pliva Pharm & Chem Works | Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof |
US4474768A (en) * | 1982-07-19 | 1984-10-02 | Pfizer Inc. | N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor |
WO1989002271A1 (en) * | 1987-09-10 | 1989-03-23 | Pfizer | Azithromycin and derivatives as antiprotozoal agents |
US5605889A (en) | 1994-04-29 | 1997-02-25 | Pfizer Inc. | Method of administering azithromycin |
WO1996019489A1 (en) * | 1994-12-19 | 1996-06-27 | Russinsky Limited | Compounds |
US5872104A (en) | 1994-12-27 | 1999-02-16 | Oridigm Corporation | Combinations and methods for reducing antimicrobial resistance |
CN1205338A (zh) * | 1998-05-08 | 1999-01-20 | 刘万忠 | 阿奇霉素水溶性盐的合成新方法及其在医药上的用途 |
TW546302B (en) | 1998-05-08 | 2003-08-11 | Biochemie Sa | Improvements in macrolide production |
US6239112B1 (en) | 1998-07-09 | 2001-05-29 | Merial, Inc. | Water miscible macrolide solutions |
PT1152765E (pt) * | 1998-11-30 | 2004-12-31 | Teva Pharma | Etanolato de azitromicina, processo de preparacao e composicoes farmaceuticas que os contem |
US6239113B1 (en) * | 1999-03-31 | 2001-05-29 | Insite Vision, Incorporated | Topical treatment or prevention of ocular infections |
IT1313610B1 (it) * | 1999-08-09 | 2002-09-09 | S I F I Societa Ind Farmaceuti | Processo per la preparazione di formulazioni acquose per uso oftalmico |
-
2002
- 2002-10-18 DE DE60232005T patent/DE60232005D1/de not_active Expired - Fee Related
- 2002-10-18 WO PCT/US2002/033339 patent/WO2003032922A2/en not_active Application Discontinuation
- 2002-10-18 AT AT02801784T patent/ATE428403T1/de not_active IP Right Cessation
- 2002-10-18 HU HU0402291A patent/HUP0402291A2/hu unknown
- 2002-10-18 ES ES02801784T patent/ES2324527T3/es not_active Expired - Lifetime
- 2002-10-18 IL IL16139802A patent/IL161398A0/xx unknown
- 2002-10-18 AU AU2002335087A patent/AU2002335087A1/en not_active Abandoned
- 2002-10-18 US US10/274,097 patent/US6764997B2/en not_active Expired - Fee Related
- 2002-10-18 EP EP02801784A patent/EP1446010B1/en not_active Expired - Lifetime
- 2002-10-18 CA CA002463619A patent/CA2463619C/en not_active Expired - Fee Related
- 2002-10-18 PT PT02801784T patent/PT1446010E/pt unknown
- 2002-10-18 DK DK02801784T patent/DK1446010T3/da active
-
2004
- 2004-04-13 US US10/822,773 patent/US20040192622A1/en not_active Abandoned
- 2004-09-07 US US10/936,075 patent/US20050106239A1/en not_active Abandoned
-
2005
- 2005-02-02 HK HK05100860.2A patent/HK1067278A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU2002335087A1 (en) | 2003-04-28 |
CA2463619A1 (en) | 2003-04-24 |
WO2003032922A3 (en) | 2003-10-16 |
HUP0402291A2 (hu) | 2005-03-29 |
US20050106239A1 (en) | 2005-05-19 |
DK1446010T3 (da) | 2009-06-22 |
EP1446010A2 (en) | 2004-08-18 |
US20040192622A1 (en) | 2004-09-30 |
ES2324527T3 (es) | 2009-08-10 |
PT1446010E (pt) | 2009-06-08 |
EP1446010B1 (en) | 2009-04-15 |
EP1446010A4 (en) | 2007-06-13 |
US6764997B2 (en) | 2004-07-20 |
DE60232005D1 (de) | 2009-05-28 |
IL161398A0 (en) | 2004-09-27 |
ATE428403T1 (de) | 2009-05-15 |
CA2463619C (en) | 2008-05-06 |
WO2003032922A2 (en) | 2003-04-24 |
US20030176369A1 (en) | 2003-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1067278A1 (en) | Stabilized azithromycin compositions | |
ZA974982B (en) | Acidic cleaning compositions containing xanthan gum. | |
MXPA05001061A (es) | Composiciones farmaceuticas, acuosas de 2,6-diisopropilfenol. | |
AU2002215344A1 (en) | Compositions containing carotenoids and tocotrienols and having synergistic antioxidant effect | |
EP1469743A4 (en) | STABLE HYGROSCOPIC COMPOSITIONS AND METHODS FOR STABILIZING HYGROSCOPIC INGREDIENTS | |
AU1870099A (en) | Stabilised insulin compositions | |
EA200301275A1 (ru) | Капсулы для ингаляции | |
PL343156A1 (en) | Method for stabilizing pharmaceutical compositions by special use of an antioxidant | |
TW200633716A (en) | Compositions and methods for stabilizing active pharmaceutical ingredients | |
ES2130575T3 (es) | Composiciones inmunogenicas mejoradas contra la gastrina 17 humana. | |
HUP0400832A3 (en) | New amidoalkyl-piperidine and amidoalkyl-piperazine derivatives, and pharmaceutical compositions containing such derivatives as active ingredients | |
NZ511085A (en) | Oral pharmaceutical compositions containing buprenorphin | |
MY131488A (en) | Low dose liquid entecavir formulations and use | |
CO5580729A2 (es) | Composiciones nutricionales que comprenden cistationina | |
TW200517117A (en) | Stabilized compositions containing an oxygen-labile active agent | |
IL146284A0 (en) | Androgen glycosides and pharmaceutical compositions containing the same | |
AU2003223732A1 (en) | Electron field emitter and compositions related thereto | |
HUP0303420A3 (en) | Synergetic fungicidal compositions based on pyridylmethylbenzamide and propamocarb derivative and use thereof | |
MXPA05010796A (es) | Composiciones solidas suaves con sineresis reducida. | |
EP1541134A3 (en) | Stabilized azithromycin compositions | |
MXPA04006005A (es) | Formulacion oral de fludara purisimo con liberacion rapida del ingrediente activo. | |
AU2002347973A1 (en) | Novel tibolone formulations | |
MY136633A (en) | Stabilized brivudine topical formulations | |
IL157849A0 (en) | Pharmaceutical compositions containing (+) cannabidiol and derivatives thereof and some such novel derivatives | |
ATE208627T1 (de) | Orale zusammensetzungen mit niedrigdosierten zytotoxischen proteinen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20121018 |